As Filed with the Securities and Exchange Commission on July 24, 2003,
Commission  File  No.  I-08675

                            SCHEDULE  14A INFORMATION

                  Proxy Statement Pursuant to Section 14(a) of
                       the Securities Exchange Act of 1934

Filed  by  Registrant  [X]
Filed  by  a  Party  other  than  the  Registrant  [  ]
Check  the  appropriate  box:
[ ]  Preliminary  Proxy  Statement
[ ]  Confidential  for  use  of  the  Commission  Only  (as  permitted  by Rule
     14a-6(e)(2))
[X]  Definitive  Proxy  Statement
[ ]  Definitive  Additional  Materials
[ ]  Soliciting  Material  Pursuant  to  240.14a-12

                       UNITED STATES ANTIMONY CORPORATION
                       ----------------------------------
                (Name of Registrant as Specified in its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment  of  Filing  Fee  (Check  the  appropriate  box):
[X]  No  fee  required.
[ ]  Fee  computed  on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)  Title  of  each  class  of  securities  to  which  transaction  applies:
(2)  Aggregate  number  of  securities  to  which  transaction  applies:
(3) Per unit price or other underlying value of transaction computed pursuant to
Exchange  Act  Rule  0-11  (set  forth  the  amount  on  which the filing fee is
calculated  and  state  how  it  was  determined):  n/a.
(4)  Proposed  maximum  aggregate  value  of  transaction:  n/a
(5)  Total  fee  paid:  -0-


[ ]  Fee  paid  previously  with  preliminary  materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2)  and  identify  the  filing  for  which  the  offsetting fee was paid
previously.  Identify  the  previous filing by registration statement number, or
the  Form  or  Schedule  and  the  date  of  its  filing.

(1)  Amount  Previously  Paid:
(2)  Form,  Schedule  or  Registration  Statement  No.:
(3)  Filing  Party:
(4)  Date  filed:
                                             1

                       United States Antimony Corporation
                      PO Box 643, Thompson Falls, Mt. 59873
                                  JULY 31, 2003
Dear  Stockholder:

You are cordially invited to attend the Annual Meeting of Shareholders of United
States  Antimony  Corporation,  which will be held at 10:00 a.m. Spokane Time on
September  30,  2003  at  the  Ramada  Inn  located  adjacent  to  the  Spokane
International  Airport,  8909  Airport  Road,  Spokane,  Washington.

Those  matters  expected to be acted upon at the meeting are described in detail
in  the  attached  Notice of Annual Meeting of Shareholders and Proxy Statement.

The  enclosed notice and proxy statement contain details concerning the business
to  come  before  the  meeting.  We  have also enclosed for your information and
review  the  Annual Report on Form 10-KSB for the fiscal year ended December 31,
2002.

The  board  of  directors  recommends  a  vote  FOR each of the proposals below:

"FOR" electing  John C. Lawrence, Robert A. Rice and Leo Jackson to our board of
directors  to  serve  for  the  ensuing  year or until their successors are duly
elected  and  qualified;

"FOR"  the  amendment of the Company's Articles of Incorporation, authorizing an
increase  of  the number of authorized shares of Common Stock from 30,000,000 to
50,000,000  shares;  and

"FOR"  the  appointment  of  the auditors for the year ending December 31, 2003.

All  shareholders  are  cordially  invited to attend the Meeting in person. Your
participation  at  this  meeting  is very important, regardless of the number of
shares you hold. Whether or not you plan to attend the meeting, please complete,
date,  sign  and  return  the  accompanying  proxy  promptly.  If you attend the
Meeting,  you  may  revoke  your  proxy  and  vote  your  shares  in  person.
We  look  forward  to  seeing  you  at  the  Meeting.
Sincerely,

/s/  John  C.  Lawrence
John  C.  Lawrence,  President,  Chief  Financial  Officer  and  Director
--------------------------------------------------------------------------------
This  Proxy  Statement and the accompanying proxy card are first being mailed to
United  States  Antimony  Corporation  shareholders  beginning  July  31,  2003.
                                          2

                       UNITED STATES ANTIMONY CORPORATION
               NOTICE OF ANNUAL  MEETING OF SHAREHOLDER TO BE HELD
                              ON SEPTEMBER 30, 2003
To  our  Shareholders:
NOTICE  is  hereby  given  that  on  September  30,  2003 United States Antimony
Corporation  will  hold  its  Annual  Meeting of Shareholders at the Ramada Inn,
located  adjacent  to  the  Spokane  International  Airport,  8909 Airport Road,
Spokane,  Washington.  The meeting will begin at 10:00 a.m. Spokane Time. At the
meeting,  shareholders  will  be  asked:

1.     To  elect  John C. Lawrence, Robert A. Rice and Leo Jackson  to our board
of  directors  to  serve for the ensuing year or until their successors are duly
elected  and  qualified.
2.     To  amend  the Company's Articles of Incorporation to increase the number
of  authorized  shares  of  Common  Stock  from  30,000,000 shares to 50,000,000
shares;  and
3.     To  ratify  the  appointment  of  DeCoria,  Maichel & Teague, P.S. as the
Company's  independent  auditors  to  examine  the  financial  statements of the
Company  for  the  fiscal  year  ending  December  31,  2003.
4.     To  transact  such  other business as may properly come before the Annual
Meeting  or  any  postponements  or  adjournments  thereof.

We  have  enclosed  for the review of our shareholders the Annual Report on Form
10-KSB  for  the  fiscal  year ended December 31, 2002, which was filed with the
Securities  and Exchange Commission on April 14, 2003. The Company is unaware of
any  other  business  to  be  considered  and  acted upon at the meeting and any
adjournments  thereof.  Only  shareholders of record at the close of business on
June  30,  2003,  or such other date as may be determined as the record date are
entitled  to  notice of and to vote at the meeting and any adjournments thereof.

All  shareholders  are  cordially  invited  to  attend the meeting in person. To
assure  your representation at the meeting and whether or not you plan to attend
in  person,  you are urged to mark, sign, and date and return the enclosed proxy
card  at  your earliest convenience in the self-addressed, stamped envelope. Any
stockholder  attending  the meeting may revoke their proxy and vote their shares
in  person.

Please  Sign, Date and Return the Enclosed Proxy Immediately to Assure that Your
Shares  are  represented  at  the  Annual  Meeting of Shareholders scheduled for
September  30,  2003.

By  Order  of  the  Board  of  Directors,

/s/  John  C.  Lawrence
Chairman,  President  and  Chief  Financial  Officer
Thompson  Falls,  Mt.  59873
July  31,  2003
                                   3

                       UNITED STATES ANTIMONY CORPORATION
                                 PROXY STATEMENT
                         ANNUAL MEETING OF SHAREHOLDERS
                         ------------------------------


This  Proxy  Statement  relates  to the Annual Meeting of Stockholders of United
States  Antimony Corporation Company, (the "Company"), a Montana corporation, to
be  held  on September 30, 2003, at 10:00 a.m., Spokane Time, at the Ramada Inn,
located  adjacent  to  the  Spokane  International  Airport,  8909 Airport Road,
Spokane,  Washington,  including  any adjournments or postponements thereof (the
"Meeting").  This Proxy Statement, the accompanying proxy card and the Company's
Annual  Report are first being mailed to stockholders of the Company on or about
July 31, 2003. THIS INFORMATION IS FURNISHED IN CONNECTION WITH THE SOLICITATION
BY  THE  COMPANY  OF PROXIES FROM THE HOLDERS OF THE COMPANY'S COMMON STOCK, PAR
VALUE  $0.01  PER  SHARE  ("COMMON  STOCK"),  SERIES A PREFERRED STOCK, SERIES C
PREFERRED  STOCK,  and  SERIES  D  PREFERRED  STOCK,  FOR  USE  AT  THE MEETING.

The principal solicitation of proxies is being made by mail; however, additional
solicitation  may  be  made  by  telephone,  facsimile  or  personal  visits  by
directors,  officers  and  regular  employees  of  the Company. The Company will
reimburse brokerage firms and others for their reasonable expenses in forwarding
soliciting  material.

All  shares  represented  by  duly  executed  proxies  in  the accompanying form
received prior to the Meeting will be voted in the manner specified therein. Any
stockholder  granting  a  proxy  may revoke it at any time before it is voted by
filing with the Secretary of the Company either an instrument revoking the proxy
or  a  duly  executed proxy bearing a later date. Any stockholder present at the
Meeting  who  expresses  a desire to vote their shares in person may also revoke
their  proxy.  As to any matter for which no choice has been specified in a duly
executed  proxy,  the shares represented thereby will be voted FOR each proposal
listed  herein  and  in  the discretion of the persons named in the proxy in any
other  business  that  may  properly  come  before  the  Meeting.

STOCKHOLDERS  ARE  URGED,  WHETHER  OR NOT THEY EXPECT TO ATTEND THE MEETING, TO
COMPLETE,  SIGN  AND  DATE  THE ACCOMPANYING PROXY AND RETURN IT PROMPTLY IN THE
ENCLOSED  ENVELOPE.

We  have  enclosed  for the review of our shareholders the Annual Report on Form
10-KSB  for  the  fiscal  year ended December 31, 2002, which was filed with the
Securities  and  Exchange  Commission  on  April  14,  2003.

PROPOSALS TO BE VOTED UPON BY SHAREHOLDERS AT THE ANNUAL MEETING OF SHAREHOLDERS

At the Annual Meeting, the holders of our shares of Common Stock and the holders
of  Series A,C and D Preferred Stock, will be asked to vote on the proposals set
forth  below.  Only  shareholders of record at the close of business on June 30,
2003,  the  record  date, are entitled to notice of, and to vote at, the meeting
(the  "Record Date"). At the Record Date, there were 27,027,959 shares of Common
Stock  issued  and  outstanding.  Additionally, Series A, Series C, and Series D
Preferred  Stock are entitled to vote at the Annual Meeting. As of June 30, 2003
there  were 553,404 shares of Series A, C, and D Preferred Stock outstanding. An
affirmative  vote of a majority of those shares present and voting at the Annual
Meeting  is  required  for  approval  of  all matters.  There are no dissenters'
rights  to  appraisal  with  respect  to  the  proposals.
                                            4


PROPOSAL  ONE:  To elect John C. Lawrence, Robert A. Rice and Leo Jackson to our
board  of  directors to serve for the ensuing year or until their successors are
duly  elected  and  qualified.

Information  Concerning  Directors: It is proposed that John C. Lawrence, Robert
A.  Rice  and  Leo  Jackson  will be elected at the meeting, each to hold office
until  the next annual meeting of shareholders and/or until their successors are
duly  elected  and  qualified.  The  Company  has  no reason to believe that any
nominee  will  be  unavailable  at  the  time  of  election.

PROPOSAL  TWO:  To amend the Company's Articles of Incorporation to increase the
authorized number of shares of Common Stock from 30,000,000 shares to 50,000,000
shares.

The  Board  of  Directors  believes that it is in the Company's best interest to
increase  the  number of authorized but unissued shares of Common Stock because:

(1)     Shares  of  common  stock  must  be  available  to  meet  the respective
conversion  and  exercise  privileges  of  the  Company's  convertible  Series D
Preferred  stock  and  common  stock  warrants.
(2)     The  Company  must  have  additional shares of common stock available to
sell  to  expand  its  Bear  River  Zeolite  business  and finance its operating
activities.
(3)     Additional  shares  of  common  stock  must  be  available  to  issue to
directors and other key employees and consultants in order to attract and retain
competent  management  for  the  Company.

By voting "FOR" this proposal, shareholders will be authorizing the amendment of
the  Articles of Incorporation to increase the number of authorized Common Stock
shares.   At the Record Date, there were 27,027,959 shares of Common Stock
issued and  outstanding. On May 28, 2003, the Board of Directors authorized the
sale of up to 1,250,000 shares of common stock. As of the Record Date, 1,350,000
shares of common stock had been sold (of which 175,000 were subscribed for prior
to  12/31/02),  but  share  certificates  have  yet  to  be  issued.

Recommendation of the Board of Directors: Our Board of Directors recommends that
our  shareholders  vote  "FOR" the amendment to the Articles of Incorporation to
increase  the  number  of  authorized  shares of Common Stock from 30,000,000 to
50,000,000  shares.

PROPOSAL THREE:  To ratify the appointment of DeCoria, Maichel & Teague, P.S. as
the  Company's  independent  auditors to examine the financial statements of the
Company  for  the  fiscal  year  ending  December  31,  2003.

Recommendation of the Board of Directors: Our Board of Directors recommends that
the  holders  of  our  shares  vote  "FOR" the appointment of DeCoria, Maichel &
Teague,  P.S.  as  the  Company's  independent auditors to examine the financial
statements  of  the  Company  for  the  fiscal  year  ending  December 31, 2003.

PROPOSAL  FOUR:  To transact such other business as may properly come before the
Annual  Meeting  or  any  postponements  or  adjournments  thereof.

                                           5


As  of  the date of this Proxy Statement, the Board of Directors is not aware of
any  matters  that will be presented for action at the Annual Meeting other than
those described above. However, should other business properly be brought before
the  Annual  Meeting, the proxies will be voted thereon in the discretion of the
persons  acting  thereunder.

The enclosed Proxy is solicited by and on behalf of the board. We are unaware of
any  additional  matters not set forth in the notice of Annual Meeting that will
be presented for consideration at the meeting. If any other matters are properly
brought  before  the  meeting  and presented for a vote of the shareholders, the
persons named in the proxy will vote in accordance with their best judgment upon
such  matters,  unless  otherwise  restricted  by  law.

ITEM  1.  DATE,  TIME  AND  PLACE  INFORMATION
This proxy statement is furnished in connection with the solicitation of proxies
for  use  at  the  meeting of shareholders of United States Antimony Corporation
Company  to  be  held  on  September  30, 2003, at 10:00 a.m. Spokane Time, 8909
Airport  Road,  Spokane,  Washington,  and  at any and all adjournments thereof.

ITEM  2.  REVOCABILITY  OF  PROXY
The  accompanying  proxy  is  solicited  by  our  board  and is revocable by the
shareholder  anytime  before  it  is  voted. This proxy statement is first being
mailed  to  shareholders  on  or  about  July  31,  2003.

ITEM  3.  DISSENTERS'  RIGHT  OF  APPRAISAL
There  is  no  Dissenters' Right of Appraisal for any proposal set forth in this
proxy  statement.

ITEM  4.  PERSONS  MAKING  THE  SOLICITATION
This solicitation is made by the Company's board, which unanimously approved the
proposals,  by  consent  and without a meeting, and no director has informed the
Company  that  he  intends  to  oppose  any  action  intended to be taken by the
Company.

ITEM  5.  INTEREST  OF  CERTAIN  PERSONS  IN  MATTERS  TO  BE  ACTED  UPON
The  following  table  sets  forth  information,  to  the  best knowledge of the
Company,  as  of  March  27,  2003,  with  respect to each person who has been a
director  or executive officer of the Company at any time since the beginning of
the  last  fiscal  year  or has been nominated for election as a director of the
Company.





                                                                                                       
                                                                                         Amount of
                                                                                        Beneficial
Title of Class. . . . . . . . . . . . . .  Name of Beneficial Owner                     Ownership        Percent of Class (1)
Common Stock. . . . . . . . . . . . . . .  John C. Lawrence                             3,725,311                 13.8 (2)
Common Stock. . . . . . . . . . . . . . .  Robert A. Rice                                 217,762  Nil
Common Stock. . . . . . . . . . . . . . .  Leo Jackson                                     60,700  Nil

                                                                                          925,213                 92.8(3)(4)
Preferred Series D. . . . . . . . . . . .  John C. Lawrence                                24,000                 25.0
Preferred Series D. . . . . . . . . . . .  Robert A. Rice                                  24,000                 25.0
Preferred Series D. . . . . . . . . . . .  Leo Jackson                                    _______                  ___
                                                                                        4,979,986                 17.8
Common Stock and Series D Preferred Stock  Directors and Executive Officers as a Group  =========                  ===


                                           6



(1)     Based  upon 27,027,959 total common stock shares outstanding as of March
27,  2003.
(2)     Excludes  75,000  shares owned by Mr. Lawrence's sister, as to which Mr.
Lawrence  disclaims  beneficial  ownership.
(3)     Includes  warrants  to  purchase  901,213  shares  of Series D Preferred
Stock.
(4)     The  outstanding  Series  D  preferred  shares  carry  voting  rights.

ITEM  6.  VOTING  SECURITIES  AND  PRINCIPAL  HOLDERS  THEREOF.

Only  shareholders  of  record  at  the  close of business on June 30, 2003, the
record  date,  are  entitled  to  notice of, and to vote at, the meeting. At the
record  date,  there  were  27,027,959  shares  of  Common  Stock  issued  and
outstanding.  Additionally, Series A, Series C, and Series D Preferred Stock are
entitled  to  vote at the Annual Meeting. As of June 30, 2003 there were 553,404
shares  of  Series A, C, and D Preferred Stock outstanding.  Each shareholder of
record of Common Stock and Series A,C, and D Preferred Stock, on the record date
is  entitled  to  one  vote per share on each proposal presented at the meeting,
(other than the election of directors)  exercisable in person or by proxy.  With
respect  to  the  election  of directors, such stockholders are entitled to vote
cumulatively,  meaning that each holder of voting shares is entitled to cast the
number  of  votes  equal to the number of his shares multiplied by the number of
directors  to  be elected, an may cast all of such votes for a single nominee or
distribute  them  among  two  or  more  nominees  as  he  sees  fit.

The  presence  in  person  or  by  proxy of a majority of the outstanding shares
entitled  to vote is necessary to constitute a quorum at the meeting. Assuming a
quorum  is  present,  the  affirmative  vote of the holders of a majority of the
shares  issued  and  outstanding  present  in  person or represented by proxy is
required  for  approval  of  each  proposal  to  be  voted  upon at the meeting.


The following table sets forth information regarding beneficial ownership of our
common  stock  as  of  March  27,  2003, by 1) each person who is known by us to
beneficially  own  more  than 5% of our Series A, Series C or common stock; (ii)
each  of  our  executive  officers and directors; and (iii) all of our executive
officers  and  directors  as  a  group.  Unless  otherwise stated, each person's
address  is  c/o United States Antimony Corporation, P.O. Box 643, 1250 Prospect
Creek  Road,  Thompson  Falls,  Montana  59873.




                                                                                       
                                          NAME AND ADDRESS OF            AMOUNT AND NATURE OF   PERCENT OF
TITLE OF CLASS . . . . . . . . . . . . .  BENEFICIAL OWNER(1)            BENEFICIAL OWNERSHIP   CLASS(1)
----------------------------------------  -----------------------------  ---------------------  -----------
Common stock . . . . . . . . . . . . . .  The Maguire Family and                  1,401,898(2)          5.2
                                          related entities as a group
                                          c/o Walter L. Maguire, Sr.
                                          P.O. Box 129
                                          Keller, VA 23401
Common stock . . . . . . . . . . . . . .  The Dugan Family                        5,520,116(4)         19.0
                                          c/o A. W. Dugan
                                          1415 Louisiana Street, Suite 3100
                                          Houston, TX 77002
Preferred Series A . . . . . . . . . . .  A. Gordon Clark, Jr.                        4,500(7)        100.0
stock. . . . . . . . . . . . . . . .      2 Musket Trail
                                          Simsbury, CT 06070
Preferred Series C . . . . . . . . . . .  Walter L. Maguire, Sr.                     49,091(7)         27.6
stock. . . . . . . . . . . . . . . . . .  P.O. Box 129
                                          Keller, VA 23401
Preferred Series C . . . . . . . . . . .  Richard A. Woods                           48,305(7)         27.2
stock. . . . . . . . . . . . . . . .      59 Penn Circle West
                                          Penn Plaza Apts.
                                          Pittsburgh, PA 15206
Preferred Series C . . . . . . . . . . .  Dr. Warren A. Evans                        48,305(7)         27.2
stock. . . . . . . . . . . . . . . . . .  69 Ponfret Landing Road
                                          Brooklyn, CT 06234
Preferred Series C . . . . . . . . . . .  Edward Robinson                            32,203(7)         18.1
stock. . . . . . . . . . . . . . . . . .  1007 Spruce Street 1st Floor
                                          Philadelphia, PA 19107
                                              7


Preferred Series D . . . . . . . . . . .  Gary D. Babbitt                           274,000(5)(7)      79.2
                                          877 W. Main Street, Suite 1000
                                          Boise, ID 83702

Common stock . . . . . . . . . . . . . .  John C. Lawrence                        3,725,311(3)         13.8
Common stock . . . . . . . . . . . . . .  Robert A. Rice                            217,762             Nil
Common stock . . . . . . . . . . . . . .  Leo Jackson                                60,700             Nil
Preferred Series D . . . . . . . . . . .  John C. Lawrence                          925,213(6) (7)     92.8
Preferred Series D . . . . . . . . . . .  Robert A. Rice                             24,000            25.0
Preferred Series D . . . . . . . . . . .  Leo Jackson                                24,000            25.0
Common stock and
Series D Preferred Stock . . . . . . . .  All Directors and executive
                                          officers as a group
                                         (3 persons). . . . .                     4,976,986            17.8



(1)     Beneficial  Ownership  is determined in accordance with the rules of the
Securities  and  Exchange Commission and generally includes voting or investment
power  with  respect to securities. Shares of common stock subject to options or
warrants  currently  exercisable  or  convertible, or exercisable or convertible
within  60  days  of  March  27,  2003  are deemed outstanding for computing the
percentage  of  the  person  holding  options  or  warrants  but  are not deemed
outstanding  for  computing  the percentage of any other person. Percentages are
based  on a total of 27,027,959 shares of common stock, 4,500 shares of Series A
Preferred  Stock,  177,904 shares of Series C Preferred Stock, and 96,000 shares
of  Series  D  Preferred  Stock  outstanding  on  March 27, 2003, and the shares
issuable  upon  the exercise of options and warrants exercisable on or within 60
days  of  March  27,  2003,  as  described  below.

(2)     Includes  1,007,843  shares  owned  by  the  Maguire Foundation; 129,000
shares  owned  by  Walter  L.  Maguire,  Sr.;  45,500  shares owned by Walter L.
Maguire,  Trustee;  and 219,555 shares owned by Walter L. Maguire, Jr.  Excludes
1,003,409  shares  owned  by  the  1934  Maguire  Trust.

(3)     Excludes  75,000  shares owned by Mr. Lawrence's sister, as to which Mr.
Lawrence  disclaims  beneficial  ownership.

(4)     Includes  1,918,767 shares owned by A.W. Dugan; and 1,580,940 shares, in
the  aggregate,  owned  by  companies  owned  and  controlled by A.W. Dugan; and
warrants  issued  to  Mr.  Dugan  and  companies  controlled  by him to purchase
2,020,409  shares of common stock.  Excludes 183,333 shares owned by Lydia Dugan
as  to  which  Mr.  Dugan  disclaims  beneficial  ownership.

(5)     Includes  warrants  to  purchase  250,000  shares  of Series D Preferred
Stock.

(6)     Includes  warrants  to  purchase  901,213  shares  of Series D Preferred
Stock.

(7)     The  outstanding  Series A, Series C and Series D preferred shares carry
voting  rights.


ITEM  7.  DIRECTORS  AND  EXECUTIVE  OFFICERS



                                                    
NAME . . . . . .  AGE  AFFILIATION WITH REGISTRATION  EXPIRATION OF TERM
----------------  ---  -----------------------------  ------------------
John C. Lawrence   64  President, Director            Annual meeting
Robert A. Rice .   78  Director                       Annual meeting
Leo Jackson. . .   61  Director                       Annual meeting




                                          8


The  Company  is  not  aware  of  any  involvement by its directors or executive
officers  during  the  past  five  years  in  certain legal proceedings that are
material  to  an  evaluation  of  the  ability  or integrity of such director or
executive  officer.

The  following  information  with  respect  to  the  principal  occupation  or
employment,  other  affiliations  and  business experience of each member of the
board  of  directors  during  the  last  five  years.

John  C.  Lawrence.  Mr.  Lawrence  has been the president and a Director of the
Company  since  its  inception. Mr. Lawrence was the President and a Director of
AGAU  Mines,  Inc.,  the predecessor of the Company, since the inception of AGAU
Mines,  Inc.,  in  1968. He is a member of the Society of Mining Engineers and a
recipient  of  the  Silver  Medallion  Award  from  the  University  of Montana.

Robert  A. Rice. Mr. Rice is a retired metallurgist, having been employed by the
Bunker  Hill  Mining  Company,  a  wholly owned subsidiary of Gulf Resources and
Chemical Corporation as Mill Superintendent from  1965  until his retirement
in 1975.  Bunker  Hill  Mining  Company was located at Kellogg, Idaho. He
currently serves as President and a Director of Nabob Silver-Lead, Co., an Idaho
Corporation,  Box  506, Silverton, Idaho, 83867; and a Director of  Merger Mines
Corp., an Arizona Corporation,  4903 Industrial Way, Coeur d'Alene, Idaho 83814.
The  common stock of Merger Mines trades on the "Pink Sheets". Mr. Rice has
been a  Director  of  the  Company  since  1975.

Leo  Jackson.  Mr.  Jackson is a resident of El Paso, Texas. He is currently the
President  and a Director of Production Minerals, Inc., a privately held entity.
Production  Minerals,  Inc. offices are located at 663 North Mesa, Suite 504,
El Paso, Texas 79912. He has been involved in the production and marketing
Of industrial minerals such as fluorspar and celestite in the United States and
Mexico for 25 years. Mr. Jackson speaks fluent Spanish and has a BBA degree from
the  Sul  Ross State University in Texas. Mr. Jackson has been a Director of the
Company  since  1999.

COMPLIANCE  WITH  SECTION  16(A)  BENEFICIAL  OWNERSHIP  REPORTING:

Section 16(a) of the Securities Exchange Act of 1934 requires that the Company's
directors and executive officers and the holders of 10% or more of the Company's
Common  Stock,  to  file  reports of ownership and changes in ownership with the
Securities  and  "Exchange  Commission.  Officers,  directors  and  stockholders
holding  more  than  10%  of  the  Company's  common  stock  are required by the
regulation  to  furnish  the Company with copies of all Section 16(a) forms they
have  filed.

Based  solely  on our review of copies of Forms 3, 4, and 5 furnished to us, Mr.
Lawrence  timely filed Form 4 reports during 2002. We do no know if Mr. Rice and
Mr. Jackson timely filed Form 4 or Form 5 reports during 2002. We do not know if
A.W.  Dugan,  a shareholder who became a 10% beneficial owner during 2002 timely
filed  Form  3,  Form  4,  or  Form  5  reports  during  2002.


BOARD  MEETINGS  AND  COMMITTEES

The Company's Board of Directors held eight (8) regular meetings during the
2002  calendar  year.  Each  incumbent  director  attended  at  least 75% of the
meetings  held during the 2002 calendar year, in the aggregate, by the Board and
each  committee  of  the Board of which he was a member.  The Company's Board of
Directors  does  not  have  a Compensation Committee, or a Nominating Committee.
The  Company  has established an Audit Committee consisting of one member of the
Board of Directors not involved in our day-to-day financial management. The sole
member  of  the  Audit Committee is Rice. Mr. Rice should not be considered as a
financial  expert  serving  on the audit committee. The Company does not have an
audit committee financial expert because the Company does not have the financial
resources  currently  available  to  compensate  a  financial  expert. The Audit
Committee  met twice in 2002. Additionally, the sole member of the Committee met
two  times  with  the  Company's  independent  auditors  to review the Company's
financial  statements.  The  Audit  Committee  did  receive  certain  written
disclosures  and  correspondence  from  the  Company's  independent auditors and
discussed  the  independent  accountants  independence.  The  Audit  Committee's
principal  functions  are  to  meet  with  the Company's independent auditors to
review  the  financial  statements  contained  in the Form 10-KSB, to review the
Company's  system of internal accounting controls, and to report to the Board of
Directors  thereon.


                                                   9


ITEM  8.  COMPENSATION  OF  DIRECTORS  AND  EXECUTIVE  OFFICERS
The  Securities  and  Exchange  Commission  requires the following table setting
forth  for  fiscal  years  ending  December  31,  2002,  2001,  and  2000;  the
compensation  paid  by  the  Company  to  its  principal  executive  officers.





                                                                                                  
                                          ANNUAL COMPENSATION                     LONG-TERM COMPENSATION
                                                                               AWARDS               PAYOUTS
                                          -------------------                 ------------------------------
                                                                       Restricted  Securities
                                                        Other Annual    Options/   Underlying  All Other  All Other
Name and Principal Position    Year    Salary     Bonus Compensation(1)  Awards(2) LTIP SARs   Payouts  Compensation
---------------------------  -------  --------    -----  -----------    ---------   ------    ---------   ------
John C. Lawrence, President    2002  $  96,000     N/A    $  5,538      $  2,400     None       None       None
John C. Lawrence, President    2001  $  96,000     N/A    $  5,538      $      0     None       None       None
John C. Lawrence, President    2000  $  81,000     N/A    $  4,673      $  3,250     None       None       None



(1)     Represents  earned  but  unused  vacation.
(2)     These  figures represent the fair values, as of the date of issuance, of
the  annual  Director's  fee  payable  to  Mr. Lawrence in the form of shares of
USAC's  restricted  Series  D  Preferred  stock  or  Common  Stock.

Each  of  the  members  of  the Board of Directors were awarded 24,000 shares of
Series  D  Preferred  stock  of the United States Antimony Corporation for their
participation  in  the  meeting  of  the  Board of Directors for the year ending
December  31,  2002.

Directors  are  also  reimbursed reasonable out-of-pocket expenses in connection
with  attending  meetings.

ITEM  9.  INDEPENDENT  PUBLIC  ACCOUNTANTS
The Company engaged the independent public accounting firm of DeCoria, Maichel &
Teague,  a  Professional  Services  corporation, with offices in Spokane, WA, to
conduct  the  audits  for the Company's fiscal years ended December 31, 2002 and
2001.


AUDIT  FEES.  The financial statements of the Company for 2001 through 2002 were
audited by DeCoria, Maichel & Teague. During the two most recent fiscal years or
during  any  subsequent  interim  period,  there  were  no  other  independent
accountants  engaged  by  the  Company nor did any other independent accountants
resign, decline to stand for re-election or was dismissed by the Company.  Audit
fees  paid  to  the  firm  of  DeCoria,  Maichel & Teague in connection with the
December,  2002  and  2001  audits  were  $33,000.


                                       10



FINANCIAL  INFORMATION  SYSTEMS  DESIGN  AND  IMPLEMENTATION  FEES.  The Company
incurred  no  fees  for  financial information systems design and implementation
during  2002.



ALL  OTHER  FEES. Fees for all other services rendered during 2002 were $10,135.
These  fees  consist primarily of tax compliance services ($2,335) and review of
interim  filings  ($7,800).


A representative of the Company's independent public accounting firm of DeCoria,
Maichel  and  Teague  P.S. is expected to be in attendance at the annual meeting
and  will  be  available  to  answer  shareholder  questions.

ITEM  10.  FINANCIAL  AND  OTHER  INFORMATION

The  Company's Annual Report on Form 10-KSB for the year ended December 31, 2002
(including  financial  statements  by  excluding exhibits) is enclosed with this
Proxy  Statement.  Stockholders may obtain, without cost, a copy of any exhibits
to  the  Form  10-KSB  by  writing  U.S.  Antimony  Corporation at its principal
executive office located at PO Box 643, Thompson Falls, Mt. 59873 or calling the
Company's  Secretary  at  (406)  827-3523.

The  Company  files  annual, quarterly and special reports, proxy statements and
other  information  with the SEC. You may read and copy any report, statement or
other  information  we  file  at  the  SEC's  public reference room at 450 Fifth
Street,  NW,  Washington, D.C., 20549. Please call the SEC at 1-800-SEC-0330 for
further  information  on  the  public  reference rooms. Our SEC filings are also
available  to  the public from commercial document retrieval services and at the
web  site  maintained  by  the  SEC  at  http://www.sec.gov.

ITEM  11.  AMENDMENT  OF  CHARTER,  BYLAWS  OR  OTHER  DOCUMENTS.

The Company is asking the shareholders to ratify the amendment  to paragraph one
of  Article  IV  of  the  Articles  of  Incorporation  to increase the number of
authorized  shares  of Common Stock from 30,000,000 shares to 50,000,000 shares.

Paragraph  one  of  Article  IV  of  the  Articles  of  Incorporation  currently
provides:

                                   ARTICLE IV

1.     Common  Stock.  The  aggregate number of shares of Common Stock which the
corporation  shall  have  authority  to issue is thirty million (30,000,000) and
each  of  such  shares  shall  have  a  par  value  of  one  cent  ($0.01).

The  text  of  the  proposed  amendment  to  paragraph  one  is  as  follows:

                                   ARTICLE IV

1.     Common  Stock.  The  aggregate number of shares of Common Stock which the
corporation shall have authority to issue is fifty million (50,000,000) and each
of  such  shares  shall  have  a  par  value  of  one  cent  ($0.01).

If  approved  by  the Stockholders, the Amendment will become effective upon the
filing  of  Articles  of  Amendment  with  the  Montana  Secretary  of  State.
                                  11


ITEM  12.  VOTING  PROCEDURE

The  presence, in person or by proxy, of the holders of a majority of the shares
of  outstanding  common  stock  of  the Company entitled to vote is necessary to
constitute a quorum at the Annual Meeting. The affirmative vote of a majority of
the  shares  of  common stock represented at the meeting and entitled to vote is
required  for  each proposal. Abstentions and broker non-votes are each included
in the determination of the number of shares present at the meeting for purposes
of  determining  a  quorum.  Abstentions  and broker non-votes have no effect on
determinations  of  plurality,  except  to the extent that they affect the total
votes  received  by  any  particular  candidate.
                               12


PROXY  CARD

The  undersigned,  revoking  any  previous  proxies,  hereby  appoints  John  C.
Lawrence,  proxy  of the undersigned, with full power of substitution, to attend
the  Company's  Annual  Meeting  of  Stockholders on September 30, 2003, and any
adjournments  or  postponements  thereof,  and  there  to vote the undersigned's
shares  of Common Stock of the Company on the following matters, as described in
the  Proxy  Statement for such Meeting, a copy of which has been received by the
undersigned.

Proposal  1.  Election  of  Directors  (by  cumulative  voting  rights)

The  Board  of  Directors  is  elected  by  cumulative  voting:
Each  holder  of  Voting  Stock  has  a  number  of  votes  that  is  equal
to  the  number  of  shares  of  Voting  Stock  he  owns  multiplied  by  the
number  of  Directors  to  be  elected.  The  holder  may  cast  all  of
those  votes  for  one  nominee  or  distribute  them  among  two  or  three
of  the  nominees  as  the  shareholder  sees  fit.  Since  three
Directors  are  to  be  elected  at  the  meeting,  the  total  votes  which
may  cast  in  the  election  of  Directors  is  calculated  as  follows:
Number  of  Shares  (___)  x  3  (number  of  Directors  to  be  elected)  =
Total  Votes.  Allocate  those  votes  among  the  following  three
nominees:


Nominees                           Number  of  Votes  Cast

                                For     Against        Abstain
John  C.  Lawrence             _____     _____          _____
Walter  L.  Maguire,  Sr.      _____     _____          _____
Robert  A.  Rice               _____     _____          _____

With  respect  to  each  of  Proposals  2  and  3,  mark  the
appropriate  box  with  an  "X".

Proposal  2.  Approval  of  amendment  of  Articles  of  Incorporation
to  increase  authorized  shares  of  Common  Stock

     [   ]   For         [   ]   Against     [   ]   Abstain

Proposal  3.  Ratification  of  independent  auditors

     [   ]   For         [   ]   Against     [   ]   Abstain

Proposal  4.     In  his discretion on all other business that may properly come
before  the  meeting  or  any  adjournment  or  adjournments  thereof.


            Sign  and  date  proxy  card  on  reverse  side

                                  13



           UNITED  STATES  ANTIMONY  CORPORATION  -  PROXY
        ANNUAL  MEETING  OF  STOCKHOLDERS  -  September  30,  2003


THIS  PROXY  IS  SOLICITED  ON  BEHALF  OF  THE  BOARD  OF  DIRECTORS.
THIS  PROXY,  IF  PROPERLY  EXECUTED,  WILL  BE  VOTED  IN  THE  MANNER
DIRECTED  HEREIN  BY  THE  UNDERSIGNED  STOCKHOLDER.  IF  NO  DIRECTION
IS  GIVEN,  THIS  PROXY WILL BE VOTED FOR THE ELECTION OF THE THREE NOMINEES FOR
DIRECTORS  AND  FOR  ADOPTION  OF  PROPOSITIONS  2  and  3.

This  proxy  confers  on  the  proxy  holder  discretionary  authority  to
vote  the  undersigned's  shares  of  Voting  Stock  on  any  other
matters  which  may  properly  be  presented  at  the  Annual  Meeting.

PLEASE  VOTE  (on  reverse  side)  AND  DATE  AND  SIGN  YOUR  NAME(S)
EXACTLY  AS  PRINTED  ON  THIS  PROXY,  indicating  (where  applicable)
official  position  or  representative  capacity. YOU SHOULD PROMPTLY RETURN THE
PROXY  CARD  USING  THE  ENCLOSED  ENVELOPE.


                              ______________________________
                              Signature


                              ______________________________
                              Date

                                14